Paper8409396
Xid-associated resistance to experimental Chagas' disease is IFN-gamma dependent.
Minoprio P and 6 others. J Immunol, 1993. Cited by 81 papers, by iCite.
Cite this record
ConductScience Library. Xid-associated resistance to experimental Chagas' disease is IFN-gamma dependent. Papers, record 8409396. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8409396
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chagas Disease | Major topic |
| Immunologic Deficiency Syndromes | Major topic |
| Interferon-gamma | Major topic |
| Animals | |
| Base Sequence | |
| Genetic Linkage | |
| Immunity, Innate | |
| Interleukin-10 | |
| Interleukin-2 | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Molecular Sequence Data | |
| Polymerase Chain Reaction | |
| X Chromosome |
Source PubMed
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35071041 | Trypanosoma cruzi Induces B Cells That Regulate the CD4+ T Cell Response. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/35071041 | PubMed |
| 33931590 | Bruton's tyrosine kinase regulates gut immune homeostasis through attenuating Th1 response. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/33931590 | PubMed |
| 32799361 | Host-parasite dynamics in Chagas disease from systemic to hyper-local scales. | Parasite Immunol | 2021 | https://conductscience.org/library/papers/32799361 | PubMed |
| 31338088 | B-1 Cells May Drive Macrophages Susceptibility to Trypanosoma cruzi Infection. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31338088 | PubMed |
| 31085707 | T-Cell Immunophenotyping and Cytokine Production Analysis in Patients with Chagas Disease 4 Years after Benznidazole Treatment. | Infect Immun | 2019 | https://conductscience.org/library/papers/31085707 | PubMed |
| 30941496 | B-1 cell response in immunity against parasites. | Parasitol Res | 2019 | https://conductscience.org/library/papers/30941496 | PubMed |
| 30662439 | Activation of Human CD11b+ B1 B-Cells by Trypanosoma cruzi-Derived Proteins Is Associated With Protective Immune Response in Human Chagas Disease. | Front Immunol | 2018 | https://conductscience.org/library/papers/30662439 | PubMed |
| 30197647 | The Unsolved Jigsaw Puzzle of the Immune Response in Chagas Disease. | Front Immunol | 2018 | https://conductscience.org/library/papers/30197647 | PubMed |
| 28626451 | Dependency of B-1 Cells in the Maintenance of Splenic Interleukin-10 Producing Cells and Impairment of Macrophage Resistance in Visceral Leishmaniasis. | Front Microbiol | 2017 | https://conductscience.org/library/papers/28626451 | PubMed |
| 26694585 | Epstein-Barr virus-induced gene 3 suppresses T helper type 1, type 17 and type 2 immune responses after Trypanosoma cruzi infection and inhibits parasite replication by interfering with alternative macrophage activation. | Immunology | 2016 | https://conductscience.org/library/papers/26694585 | PubMed |
| 25197170 | Trypanosoma cruzi infection in genetically selected mouse lines: genetic linkage with quantitative trait locus controlling antibody response. | Mediators Inflamm | 2014 | https://conductscience.org/library/papers/25197170 | PubMed |
| 24651711 | The use of a heterogeneously controlled mouse population reveals a significant correlation of acute phase parasitemia with mortality in Chagas disease. | PLoS One | 2014 | https://conductscience.org/library/papers/24651711 | PubMed |
| 23409175 | A parent-of-origin effect determines the susceptibility of a non-informative F1 population to Trypanosoma cruzi infection in vivo. | PLoS One | 2013 | https://conductscience.org/library/papers/23409175 | PubMed |
| 23209478 | Trypanosoma cruzi SSP4 Amastigote Protein Induces Expression of Immunoregulatory and Immunosuppressive Molecules in Peripheral Blood Mononuclear Cells. | J Trop Med | 2012 | https://conductscience.org/library/papers/23209478 | PubMed |
| 22315659 | B-Cell Response during Protozoan Parasite Infections. | J Parasitol Res | 2012 | https://conductscience.org/library/papers/22315659 | PubMed |
| 22110377 | A DNA vaccine encoding for TcSSP4 induces protection against acute and chronic infection in experimental Chagas disease. | Int J Biol Sci | 2011 | https://conductscience.org/library/papers/22110377 | PubMed |
| 20625554 | Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice. | PLoS Negl Trop Dis | 2010 | https://conductscience.org/library/papers/20625554 | PubMed |
| 19262989 | Killer B lymphocytes: the evidence and the potential. | Inflamm Res | 2009 | https://conductscience.org/library/papers/19262989 | PubMed |
| 18922915 | A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans. | Cancer Res | 2008 | https://conductscience.org/library/papers/18922915 | PubMed |
| 18781477 | Recombinant cardiac myosin fragment induces experimental autoimmune myocarditis via activation of Th1 and Th17 immunity. | Autoimmunity | 2008 | https://conductscience.org/library/papers/18781477 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8409396
GET https://conductscience.org/api/papers/v1/8409396/cited_by?page=2